Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Cancer-specific survival Elderly patients Multicenter study Overall survival Upper urothelial carcinoma

Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
11 Aug 2023
Historique:
received: 23 03 2023
revised: 26 07 2023
accepted: 04 08 2023
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: aheadofprint

Résumé

Upper tract urothelial carcinoma is rare but has a poor prognosis. Prognostic factors have been extensively studied in order to provide the best possible management for patients. We have aimed to investigate commonly available factors predictive of recurrence and survival in this patient population at high risk of death and recurrence, with an emphasis on the effects of age (using a cutoff of 70 years) on survival outcomes. From 1387 patients with clinically nonmetastatic upper tract urothelial carcinoma treated with radical nephroureterectomy at 21 academic hospital centers between 2005 and 2021, 776 patients were eligible and included in the study. Univariable and multivariable Cox regression models were built to evaluate the independent prognosticators for intravesical and extravesical recurrence, overall survival, and cancer-specific survival according to age groups. A P value of <.05 was considered statistically significant. We did not find an association between groups aged <70 and >70 years old and preoperatively clinical or histopathological characteristics. Kaplan-Meier analysis was found no statistical significance between the 2 age groups in terms of intravesical or extravesical recurrence (P = .09 and P = .57). Overall survival (P = .0001) and cancer-specific survival (P = .0001) have been found to be statistically significantly associated with age as independent predictors (confounding factors: gender, tumor size, tumor side, clinical T stage, localization, preoperative hydronephrosis, tumor localization, type of surgery, multifocality of the tumor, pathological grade, lymphovascular invasion, concomitant CIS, lymph node status, necrosis, or history of previous bladder cancer). This research confirms that patients aged 70 and above who undergo radical nephroureterectomy may have worse outcomes compared to younger patients, older patients needing an improved care and management of UTUC to improve their outcomes in the setting of an increase in this aged population group.

Identifiants

pubmed: 37661507
pii: S1558-7673(23)00184-2
doi: 10.1016/j.clgc.2023.08.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Matteo Ferro (M)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology Oncology, Faculty of Medicine and Surgery, University of Milan, Milan, Italy. Electronic address: matteo.ferro@ieo.it.

Sever Chiujdea (S)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Urology, Medical University of Vienna, Wien, Austria; The Institution Organizing University Doctoral Studies (I.O.S.U.D.), George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology from Târgu Mureș, Târgu Mureș, Romania.

Mihai Dorin Vartolomei (MD)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Urology, Medical University of Vienna, Wien, Austria; The Institution Organizing University Doctoral Studies (I.O.S.U.D.), George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology from Târgu Mureș, Târgu Mureș, Romania.

Pierluigi Bove (P)

San Carlo di Nancy Hospital, Rome, Italy; Department of Experimental Medicine, Tor vergata Oncoscience Research Centre of Excellence, TOR, University of Rome Tor Vergata, Rome, Italy.

Angelo Porreca (A)

Oncological Urology, Veneto Institute of Oncology (IOV), IRCCS, Padua, Italy.

Gian Maria Busetto (GM)

Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.

Francesco Del Giudice (F)

Department of Maternal Infant and Urologic Sciences, "Sapienza" University of Rome, Policlinico Umberto I Hospital, Rome, Italy.

Alessandro Antonelli (A)

Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Nazario Foschi (N)

Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Marco Racioppi (M)

Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Riccardo Autorino (R)

Department of Urology, Rush University Medical Center, Chicago, IL.

Francesco Chiancone (F)

Department of Urology, A.O.R.N. A. Cardarelli, Naples, Italy.

Nicola Longo (N)

Urology Unit, Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.

Biagio Barone (B)

Urology Unit, Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.

Felice Crocetto (F)

Urology Unit, Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.

Gennaro Musi (G)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology Oncology, Faculty of Medicine and Surgery, University of Milan, Milan, Italy.

Stefano Luzzago (S)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Mattia Luca Piccinelli (ML)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Francesco Alessandro Mistretta (FA)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Ottavio de Cobelli (O)

Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology Oncology, Faculty of Medicine and Surgery, University of Milan, Milan, Italy.

Octavian Sabin Tataru (OS)

The Institution Organizing University Doctoral Studies (I.O.S.U.D.), George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology from Târgu Mureș, Târgu Mureș, Romania; Department of Simulation Applied in Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology from Târgu Mureș, Târgu Mureș, Romania.

Rodolfo Hurle (R)

Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Giovanni Liguori (G)

Urology Clinic, Department of Medical, Surgical and Health Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy.

Marco Borghesi (M)

Department of Urology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Surgical Integrated Sciences (DISC), Urology Section, University of Genova, Genova, Italy.

Alessandro Veccia (A)

Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Francesco Greco (F)

Department of Urology, IRCCS Humanitas Gavazzeni, Bergamo, Italy.

Luigi Schips (L)

Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio, University of Chieti, Chieti, Italy.

Michele Marchioni (M)

Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio, University of Chieti, Chieti, Italy.

Giuseppe Lucarelli (G)

Urology, Andrology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.

Daniele Dutto (D)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Fulvia Colucci (F)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Giorgio Ivan Russo (GI)

Department of Surgery, Urology Section, University of Catania, Catania, Italy.

Arturo Lo Giudice (AL)

Department of Surgery, Urology Section, University of Catania, Catania, Italy.

Emanuele Montanari (E)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Luca Boeri (L)

Department of Urology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Giuseppe Simone (G)

Department of Urology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Matteo Rosazza (M)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Simone Livoti (S)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Paolo Gontero (P)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Francesco Soria (F)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Classifications MeSH